← SynDRA
UNESBULIN
SynDRA canonical compound SYN0040005 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | BMI1 |
| Mechanism of action | polycomb protein inhibitor |
| Indication | glioma |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- polycomb protein inhibitor
- BMI1 INHIBITOR
Cross-references
Synonyms
- Bmi1 inhibitor ptc596
- PTC-596
- PTC596
- 4,6-PYRIMIDINEDIAMINE, 5-FLUORO-2-(6-FLUORO-2-METHYL-1H-BENZIMIDAZOL-1-YL)-N4-(4-(TRIFLUOROMETHYL)PHENYL)-
- 5-fluoranyl-2-(6-fluoranyl-2-methyl-benzimidazol-1-yl)-~{N}4-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine
- 5-FLUORO-2-(6-FLUORO-2-METHYL-1H-BENZIMIDAZOL-1-YL)-N4-(4-(TRIFLUOROMETHYL)PHENYL)-4,6-PYRIMIDINEDIAMINE
- 5-fluoro-2-(6-fluoro-2-methyl-1H-benzimidazol-1-yl)-N4-[4-(trifluoromethyl)phenyl]-4,6-pyrimidinediamine
- 5-Fluoro-2-(6-fluoro-2-methyl-1H-benzo(d)imidazole-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine
- 5-Fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazol-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine
- 5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine
- AC-32587
- AKOS030528004
- BCP33231
- BMI1 inhibitor PTC596
- BS-15871
- C19H13F5N6
- CHEMBL4594353
- CS-0042474
- D83695
- EX-A3263
- HY-112041
- s8820
- SCHEMBL15741319
- SOZ
- TWLWOOPCEXYVBE-UHFFFAOYSA-N
- UNESBULIN [INN]
- Unesbulin [USAN]
- UNESBULIN [WHO-DD]
- UNII-Z4HZ70S62Q
- WHO 11570
- Z4HZ70S62Q
- PTC 596
- RefChem:193123
- Unesblin (USAN)
- Unesbulin (PTC596)
- orb1309210
- SCHEMBL29377707
- SCHEMBL29471411
- SCHEMBL30544391
Look up UNESBULIN in the interactive SynDRA portal →